Harbour Investments’s Pliant Therapeutics PLRX Stock Holding History

Harbour Investments’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$615	Buy	+488	New	+$616	﹤0.01%	4212
2024 Q1	–	Sell	-25	Closed	-$453	–	3288
2023 Q4	$453	Hold	25	–	–	﹤0.01%	2942
2023 Q3	$434	Buy	+25	New	+$433	﹤0.01%	2820
2021 Q4	–	Sell	-381	Closed	-$6K	–	3419
2021 Q3	$6K	Buy	381 +31	+9%	+$658	﹤0.01%	2919
2021 Q2	$10K	Buy	350 +2	+0.6%	+$62	﹤0.01%	2741
2021 Q1	$14K	Buy	+348	New	+$11.3K	﹤0.01%	2425

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Harbour Investments's PLRX Position: Q1 2026 in Review

Harbour Investments opened a new position in Pliant Therapeutics (PLRX) in Q1 2026: 488 shares worth $615. The stake represents ﹤0.01% of the portfolio and ranks #4212 among its holdings. This is a return to the name: Harbour Investments previously reported a position in PLRX as recently as Q4 2023.

Harbour Investments first reported a position in PLRX in Q1 2021 and has held it in 6 quarters since. The position peaked at $14K in Q1 2021. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

Harbour Investments held 488 shares of Pliant Therapeutics worth $615 as of Q1 2026.
Pliant Therapeutics was a new Harbour Investments position in Q1 2026.
Pliant Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4212 holding.
Harbour Investments first reported a position in Pliant Therapeutics in Q1 2021 and has held it in 6 quarters since.
Harbour Investments's Pliant Therapeutics position peaked at $14K in Q1 2021.
91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.